iNOwill Series
Relying on the NOGMT technology platform system created by Novlead, the iNOwill Series nitric oxide therapy device can achieve accurate and stable high-purity nitric oxide gas output for a long time. With one-fifth of the volume of a traditional steel cylinder, the product provides a stable gas capacity for 120 hours of operation and is easy to move without barriers, thus saying farewell to the tedious steps and high operation costs of cylinder transportation, storage, and recycling.
Main Applications:
● Neonatal ICU: for the treatment of pulmonary hypertension and hypoxic respiratory failure in newborns;
● Cardiac Surgery: for the relief and treatment of preoperative and postoperative pulmonary hypertension, as well as intraoperative use in conjunction with extracorporeal circulation to reduce postoperative low cardiac output syndrome;
● Adult ICU: for idiopathic pulmonary hypertension (iPAH), acute respiratory distress syndrome (ARDS), acute hypoxic respiratory failure (AHRF), pulmonary hypertension crisis, ECMO Co-administration, and other conditions secondary to pulmonary hypertension.
Innovations of Integrated Engineering:
● Sophisticated, compact and replaceable micro-release control reactor, incorporating sustained release and dynamic control technologies, ensures a sustainable supply of NO by simply replacing the micro-release control reactors at regular intervals.
● The high precision flow sensor combined with intelligent compensation technology ensures fast, accurate and constant NO gas output over long periods of time. NO concentration can still be accurately controlled under high-frequency oscillatory ventilation, and different doses and modes of NO output can be realized according to application scenarios.
● Phase-change sensor sampling technology allows real-time and high-precision monitoring of NO, NO2 and O2 concentrations, ensuring safe and reliable clinical treatment.
Product Features:
● Instant Generation: electrochemical catalytic method generates NO instantly, which is directly supplied to the patient through the integrated gas delivery system without the need of gas storage cylinders.
● Intelligent Quantitative Measurement: equipped with a high-precision flow sensor that samples 250 times per second, it intelligently adjusts the NO infusion concentration by monitoring the flow changes in real time. Precise control of inhaled NO concentration is ensured even under high-frequency oscillatory ventilation.
● Real-Time Sensing: iNOwill's innovative phase-change stabilized sampling technology enables high-precision, high-resistance and real-time monitoring of NO, NO2 and O2, and is equipped with an alarm function to meet the needs of clinical treatment.
● Safety and Reliability: A micro-release controlled reactor is only one-fifth the volume of a traditional steel cylinder and can operate stably for 120 hours at 20 ppm, thus saying goodbye to the safety risks and high operating costs associated with the transportation and storage of high-pressure gas cylinders.
